An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

Exclusion Criteria

• •Participants which did not show overall compliance of 80 to 120% with study intervention in FIGARO-DKD.
• •Participants which were not part of the full analysis set (FAS) of FIGARO-DKD.
• •Participants with known fatal outcome.
• •Participants with baseline estimated glomerular filtration rate (eGFR) ≤25 mL/min/1.73m\^2.
• •Participants with low baseline risk (normal albuminuria and eGFR≥60 mL/min/1.73m\^2).
• •Sponsor request (after discussion with the investigator), for reasons such as a significant protocol deviation.